tiprankstipranks
Trending News
More News >
Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
US Market

Amylyx Pharmaceuticals Inc (AMLX) Ownership - Who Owns Amylyx Pharmaceuticals Inc?

Compare
584 Followers

Amylyx Pharmaceuticals Inc (AMLX) Ownership Overview

9.33%6.87%46.80%6.98%30.02%
46.80% Other Institutional Investors
6.98% ETFs
30.02% Public Companies and Individual Investors
The ownership structure of Amylyx Pharmaceuticals Inc (AMLX) stock is a mix of institutional, retail, and individual investors. Approximately 60.65% of the company’s stock is owned by Institutional Investors, 9.33% is owned by Insiders, and 30.02% is owned by Public Companies and Individual Investors.
The ownership structure of Amylyx Pharmaceuticals Inc (AMLX) stock is a mix of institutional, retail, and individual investors. Approximately 53.67% of the company’s stock is owned by Institutional Investors, 9.33% is owned by Insiders, and 6.98% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 02, 2025
xxxxxxxxxxxxx
$31896
Apr 02, 2025
xxxxxxxxxxxxx
$37700
Apr 02, 2025
xxxxxxxxxxxxx
$42991
Apr 02, 2025
xxxxxxxxxxxxx
$74355

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$37477
Mar 31, 2025
xxxxxxxxxxxxx
$663080
Mar 31, 2025
xxxxxxxxxxxxx
$5697442
Mar 31, 2025
xxxxxxxxxxxxx
$27875191

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
7,874,348Institution8.83%43,466,401
3,619,737Institution4.06%19,980,948
3,429,301Institution3.85%18,929,742
3,355,280Insider3.76%18,521,146
3,355,276Insider3.76%18,521,124
1,609,447Institution1.81%8,884,147
1,150,221Institution1.29%6,349,220
1,120,022Institution1.26%6,182,521
830,661Insider0.93%4,585,249
823,920Institution0.92%4,548,038

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,429,301Institution3.85%18,929,742
670,506Institution0.75%3,701,193
493,728Institution0.55%2,725,379
384,510Institution0.43%2,122,495
346,735Institution0.39%1,913,977
189,752Institution0.21%1,047,431
157,412Institution0.18%868,914
146,500Institution0.16%808,680
65,400Institution0.07%361,008
43,171Institution0.05%238,304

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,297,241Institution2.58%11,738,902
1,135,576Institution1.27%5,802,793
387,802Institution0.44%1,848,190
372,834Institution0.42%2,058,044
324,754Institution0.36%1,792,642
238,483Institution0.27%1,316,426
186,920Institution0.21%955,161
183,055Institution0.21%1,010,464
183,055Institution0.21%1,010,464
183,055Institution0.21%1,010,464

FAQ

Who Owns Amylyx Pharmaceuticals Inc (AMLX)?
According to the latest TipRanks data, approximately 46.80% of the company's stock is held by institutional investors, 9.33% is held by insiders, and 30.02% is held by retail investors.
    What percentage of Amylyx Pharmaceuticals Inc (AMLX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 46.80% of Amylyx Pharmaceuticals Inc (AMLX) stock is held by institutional investors.
      What percentage of Amylyx Pharmaceuticals Inc (AMLX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 30.02% of Amylyx Pharmaceuticals Inc (AMLX) stock is held by retail investors.
        Who owns the most shares of Amylyx Pharmaceuticals Inc (AMLX)?
        Joseph Edelman owns the most shares of Amylyx Pharmaceuticals Inc (AMLX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis